Stockwinners Market Radar for November 14, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:30 EST Hyundai Motor names Jose Munoz as CEO - Hyundai Motor announced the appointment of Jose Munoz as the company's President and CEO, effective Jan. 1, 2025. Munoz will lead Hyundai Motor Company's global business, succeeding current President and CEO Jaehoon Chang, who has been promoted to the Vice Chair of Hyundai Motor Group - Automotive Division. Munoz joined Hyundai Motor Company in 2019 as President and Global Chief Operating Officer and President and CEO of Hyundai and Genesis Motor North America. In 2022, Munoz was announced to the Hyundai Motor Company Board of Directors with expanded responsibilities to include Europe, India, Middle East and Africa, and Asia Pacific. He also led global sales, service and product planning as part of the Global Operations Division.

20:05 EST Cathie Wood's ARK Investment bought 304K shares of Joby Aviation today

20:03 EST Cathie Wood's ARK Investment bought 266.8K shares of Personalis today

19:50 EST Tokyo Lifestyle Co Ltd (ADR) trading halted, news pending

18:38 EST Nike raises quarterly dividend 8% to 40c from 37c per share - Nike announced that its Board of Directors has declared a quarterly cash dividend of 40c per share on the company's outstanding Class A and Class B Common Stock payable on January 2, 2025, to shareholders of record at the close of business on December 2, 2024. This represents an increase of 8% versus the prior quarterly dividend rate of 37c per share. This announcement marks the 23rd consecutive year that Nike has increased its quarterly dividend.

18:30 EST Bloom Energy signs fuel cell agreement with AEP for AI data centers - Bloom Energy (BE) has signed a supply agreement with American Electric Power (AEP) for up to 1 GW of its products, the largest commercial procurement of fuel cells in the world to date. As part of this agreement, AEP has placed an order for 100 MW of fuel cells with further expansion orders expected in 2025. The agreement expands Bloom's previous work with AEP to deploy solid oxide fuel cells in commercial and industrial settings. The initial installation of Bloom's fuel cells will help meet the immediate power of AI data centers.

18:07 EST Trade Desk stockholders approve reincorporation to Nevada - Trade Desk's stockholders approved the reincorporation of the company from the State of Delaware to the State of Nevada by conversion at the company's special meeting of stockholders held on November 14.

18:03 EST MediciNova granted Notice of Allowance for MN-001 patent by USPTO - MediciNova has received a Notice of Allowance from the USPTO for a pending patent application for MN-001 - Tipelukast - to cover "Method to Decrease Triglyceride Synthesis in a Liver of a Subject." The allowed claims cover a method for decreasing triglyceride synthesis in the liver by administering MN-001 or its metabolite or pharmaceutically acceptable salt. This method is beneficial for subjects diagnosed with insulin resistance, pre-diabetes, or diabetes. Once issued, this patent is expected to expire no earlier than May 26, 2042. The Notice of Allowance is a critical step towards the issuance of the patent.

17:26 EST Eaton propellant tanks selected by MDA Space for satellite technology - Eaton announced it has been selected by MDA Space to deliver high-performance propellant storage tanks for MDA Aurora, a product line driving the transition from analog to digital satellite technology.

17:22 EST Lockheed Martin awarded $139.02M Army contract modification - Lockheed Martin was awarded a $139.02M modification to a contract for Stinger fuse/warhead body assemblies. Work locations and funding will be determined with each order, with an estimated completion date of November 30, 2027. Army Contracting Command is the contracting activity.

17:03 EST Post Holdings sees FY25 adjusted EBITDA $1.41B-$1.46B - Sees FY25 CapEx $380M-$420M.

16:58 EST Kronos Bio to present preclinical data from p300 KAT inhibitor program - Kronos Bio highlighted preclinical data from its p300 KAT inhibitor program for autoimmune indications at the American College of Rheumatology's annual meeting, ACR Convergence 2024. The oral presentation will take place on Monday, November 18. Kronos Bio has been exploring the utility of KB-7898, a p300 KAT inhibitor, for autoimmune indications given the role of interferon regulatory factor 4, or IRF4, and p300 in B cells, T cells and other immune cells. The data demonstrates the ability of p300 KAT inhibition to modulate the activity and function of multiple pro-inflammatory signaling pathways that drive chronic inflammatory diseases. In ex vivo primary cell models, the authors demonstrated that p300 KAT inhibition by KB-7898 modulated proinflammatory signaling and blunted the production of multiple clinically validated molecules that drive disease-related inflammation, including secreted IgG, IL-23, and IL-17A. P300 KAT inhibition by KB-7898 led to dose-dependent reduction up to 50% of KLH-IgG production in the Keyhole Limpet Hemocyanin booster. In a collagen-induced arthritis rat model, one of the most commonly used models for studying rheumatoid arthritis, p300 inhibition significantly decreased inflammation, as measured by joint swelling, clinical score and histopathology.

16:57 EST Starboard takes new stakes in Autodesk, Match Group - Jeffrey Smith's Starboard Value disclosed in an SEC filing its holdings as of September 30, 2024. Starboard's two new buys during the third quarter included, by size of position, Autodesk (ADSK) and Match Group (MTCH). Starboard exited three positions during the quarter, including by size of previous position, Mercury Systems (MRCY) and Aecom (ACM). Starboard increased its stake in two holdings, including Fortrea (FTRE). Starboard reduced its stake in three holdings, including by size of previous position, GoDaddy (GDDY), Humana (HUM), and Salesforce (CRM). Starboard's top holdings as of September 30, in order of size, were Autodesk, GoDaddy, Gen Digital (GEN), Salesforce, and Match Group.

16:51 EST Omega Therapeutics CEO Mahesh Karande to depart, Kaan Certel to succeed - Omega Therapeutics announced the appointment of Kaan Certel as CEO. Certel succeeds Mahesh Karande as CEO, who has decided to leave Omega for personal reasons. Certel was previously chief business officer at Omega.

16:47 EST Precision Optics announces $340,000 production order from medical device company - Precision Optics announced an initial $340,000 production order from a large, global medical device company to provide initial stocking quantities of a new single-use ophthalmic endoscope. Production is scheduled to begin in January 2025 and proceed over the following five months, to provide starting inventory levels to support product launch currently expected to occur around June 2025. The company expects follow-on orders to support first year requirements after launch with delivery rates two to three times those of this initial stocking order. The companies have previously entered into a licensing agreement that sets terms under which POC will manufacture the product or receive royalties if the product is manufactured by the customer or a third-party.

16:35 EST Ackman's Pershing Square buys Seaport, boosts Nike in Q3 - Bill Ackman's Pershing Square disclosed in an SEC filing its holdings as of September 30, 2024. The fund's one new buy during the third quarter was Seaport Entertainment (SEG). Pershing increased its stake in Brookfield (BAM) and Nike (NKE) but reduced its stake in Hilton Worldwide (HLT), Restaurant Brands (QSR), and Canadian Pacific Kansas City (CP). The fund's top holdings as of September 30, in order of size, were Brookfield, Hilton, Restaurant Brands, Chipotle (CMG), and Howard Hughes (HHH).

16:33 EST Vaccine makers fall after Trump nominates RFK to head HHS - Shares of vaccine makers, including Moderna (MRNA), BioNTech (BNTX), Pfizer (PFE), Novavax (NVAX), Vaxcyte (PCVX) and GSK (GSK) moved lower at the end of the trading day following reports that President-elect Donald Trump Donald Trump would nominate noted vaccine skeptic Robert F. Kennedy Jr. to head Health and Human Services. Trump confirmed the news after the markets closed on Thursday.

16:31 EST Campbell names Daniel Poland chief enterprise transformation officer - Campbell Soup Company announced the appointment of Daniel L. Poland to the newly created role of Executive Vice President and Chief Enterprise Transformation Officer, effective immediately. Poland will continue to report to President and Chief Executive Officer Mark Clouse and remain a member of Campbell's Operating Committee. Poland will lead a new Enterprise Transformation Office to accelerate business performance, elevate capabilities, and drive continuous improvement. Campbell's Enterprise Transformation Office is a cross-functional team to drive digital transformation, integrated business planning, innovation process, food safety and quality, sustainability, and create the supply chain network of the future. "Transformation is essential to stay nimble and to accelerate our growth in pursuit of setting the standard for performance in the food industry," said Clouse. "Our Enterprise Transformation Office will elevate critical capabilities and improve our effectiveness to create competitive advantages for the company. I'm confident Dan will bring the speed, agility and focus that transformed our supply chain to this new role and help drive our next era of growth."

16:30 EST MVB Financial names Joe Rodriguez chief risk officer - MVB Financial Corp. has named Joe Rodriguez as Chief Risk Officer. Rodriguez has a strong reputation in the financial services risk management industry as a leader who operates at the intersection of innovation and prudent risk management. "We are pleased to welcome Joe Rodriguez to the MVB family as a trusted partner on the financial frontier, committed to the success of our Team, clients, communities and shareholders," said Larry F. Mazza, CEO, MVB Financial and MVB Bank. "Known for his deep-seated expertise in banking and financial services regulatory frameworks, Joe has built a reputation for building risk management teams that are not just safeguards, but drivers of business value and sustainable transformation."

16:29 EST Natural Gas Services sees FY24 adjusted EBITDA $67M-$69M - Jacobs, Chief Executive Officer concluded, "We have multiple pathways to build on our industry-leading growth and drive shareholder value: fleet optimization, asset utilization, new rental units, and accretive mergers and acquisitions. Given our strong balance sheet, low relative leverage, and meaningful borrowing capacity, we are well positioned to continue to take advantage of the opportunities to continue significant growth beyond 2024."

16:24 EST AST SpaceMobile provides business update - The company states: "First five commercial BlueBird satellites achieved successful initial operations and filed Special Temporary Authority request with FCC to begin beta service with AT&T and Verizon: All five satellites successfully unfolded as of late October, completing a key post-launch activity; Preparing satellites for operational readiness through ongoing integration with partner networks. Secured orbital launch capacity to enable continuous space-based cellular broadband service coverage in key markets, including U.S., Europe, Japan, the U.S. Government and other strategic markets globally: Launch services agreements with Blue Origin and existing launch vehicles for launches during 2025 and 2026; The agreements enable the orbital launch of up to approximately 60 Block 2 BlueBird satellites; Achieved initial validation of our AST5000 ASIC chip, with test software, test equipment, procedures, and main infrastructure in place to commission during 2025."

16:22 EST Everi Holdings shareholders approve acquisition by Apollo Global funds - Everi Holdings (EVRI) announced that its stockholders have voted at a special meeting of Everi stockholders to approve the pending simultaneous acquisition of Everi and the Gaming & Digital business of International Game Technology (IGT) by a newly formed holding company owned by funds managed by affiliates of Apollo Global Management (APO) through a merger. As previously announced, pursuant to the terms of the merger agreement, Everi stockholders will receive $14.25 per share in cash for every share of Everi common stock they own immediately prior to the effective time of the merger. Assuming timely satisfaction of necessary closing conditions, the proposed transaction is expected to close by the end of the third quarter of 2025.

16:20 EST BioLife Solutions announces $6.1M sale of freezer subsidiary, Arctic Solutions - BioLife Solutions announces the sale of its final wholly owned freezer subsidiary, Arctic Solutions, for $6.1M in cash. "We have now completed the divestiture of all our freezer and related businesses, which began with the sale of Global Cooling in April. The sale of CBS aligns with our strategic refocus on our proprietary, higher-margin, recurring-revenue cell processing products, and away from our capital equipment freezer and storage businesses that previously included Stirling, SciSafe and CBS," commented Roderick de Greef, Chairman and CEO of BioLife Solutions.

16:17 EST Elliott sold Marathon Petroleum during Q3, bought more Southwest - Paul Singer's Elliott Investment Management disclosed in an SEC filing its holdings as of September 30, 2024. The fund's one new buy during the third quarter was Utilities Select Sector SPDR (XLU). Elliott exited two positions during the quarter: Marathon Petroleum (MPC) and iShares iBoxx $ High Yield Corporate Bond (HYG). The fund increased its stake in several holdings, including Southwest (LUV), Match Group (MTCH), Liberty Broadband (LBRDK), Western Digital (WDC) and Etsy (ETSY). Elliott decreased its stake in Seadrill (SDRL) and NRG Energy (NRG). The fund's top holdings as of September 30, in order of size, were Triple Flag (TFPM), Suncor (SU), Southwest, Pinterest (PINS), and NRG Energy.

16:16 EST Standex acquires Custom Biogenic Systems for $6.2M - Standex has acquired Michigan-based Custom Biogenic Systems for approximately $6.2M in cash. The transaction is being financed from Standex's existing cash balance. In its first year of ownership, the company expects the acquisition to be accretive to its earnings. CBS will be reported as part of Standex's Scientific business segment. Founded in 1987, Custom Biogenic Systems is a leader in the design and manufacturing of laboratory products and supplies. CBS specializes in the development and manufacturing of cryogenic equipment to the pharmaceutical and biobank end markets within life sciences. In calendar year 2024, Custom Biogenic Systems estimates revenues of approximately $15M.

16:14 EST Milestone Scientific CEO Arjan Haverhals to retire - Milestone Scientific announced that its CEO Arjan Haverhals will retire from his role as an officer of the company on December 31. Upon his retirement, Haverhals will continue to serve as a director on the board and will provide consulting services to ensure continuity and support through the leadership transition. As part of the transition, Neal Goldman, chairman of the board, has been appointed as Interim CEO, effective upon Haverhals' departure. The board is in the process of retaining an independent executive search firm to identify a permanent CEO.

16:13 EST CBRE Group COO Kohli sells 1,049 class A shares - In a regulatory filing, CBRE Group COO Vikramaditya Kohli disclosed the sale of 1,049 class A common shares of the company on November 13 at a price of $135.39 per share.

16:10 EST Bakkt sees FY24 revenue from loyalty $49M-$50M - The company states: "Full year 2024 revenue from loyalty expected to be approximately $49 million - $50 million, lower than prior guidance primarily due to lower transaction revenue. Full year 2024 gross crypto revenue, less crypto costs and execution, clearing and brokerage costs, expected to be at the lower end of $10 million - $15 million range primarily due to timing of activations. Full year 2024 cash used in operating activities expected to be ($84 million) - ($89 million) and free cash flow usage (non-GAAP) expected to be ($91 million) - ($96 million) due to reduction in revenue and higher expenses."

16:06 EST Proxy advisory firms recommend Vista Outdoor stockholders vote for CSG deal - The company states: "Vista Outdoor (VSTO) announced that both leading independent proxy advisory firms Institutional Shareholder Services and Glass Lewis & Co.have updated their reports to recommend Vista Outdoor stockholders vote "FOR" the transaction with Czechoslovak Group a.s. to acquire The Kinetic Group for $2.225 billion. The CSG Transaction will deliver to Vista Outdoor stockholders $25.75 in cash and one share of Revelyst common stock for each share of Vista Outdoor common stock they hold. Following the closing of the CSG Transaction, Revelyst will begin trading on the New York Stock Exchange under the ticker "GEAR". Subject to the receipt of necessary regulatory approvals and satisfaction of other customary closing conditions, funds managed by Strategic Value Partners, LLC will subsequently acquire Revelyst in an all-cash transaction based on an enterprise value of $1.125 billion). The SVP Transaction is expected to close by January 2025. Together, the CSG Transaction and the SVP Transaction represent an enterprise value of $3.35 billion for Vista Outdoor and will deliver an estimated $45 per share in cash to Vista Outdoor stockholders."

16:04 EST Exicure enters into purchase agreements for $1.3M - The company states: "Exicure has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company announced a significant reduction in force, suspension of preclinical activities and halting of all research and development, and that the Company was exploring strategic alternatives to maximize stockholder value. In an agreement dated November 6, 2024 and executed on November 12, 2024, the Company agreed to sell and issue to HiTron Systems Inc. 433,333 shares of common stock, par value $0.0001 per share, for $1.3 million, at a purchase price of $3.00 per share. The closing of this transaction is expected to occur within 10 days from its execution. On November 13, 2024, in a subsequent agreement, the Company agreed to sell and issue to HiTron 2,900,000 additional shares of common stock, par value $0.0001 per share, for $8.7 million, at a purchase price of $3.00 per share. The closing of the investment pursuant to this subsequent agreement is conditioned on stockholder approval, among other customary conditions."

16:00 EST Kodiak Gas Services announces $50M share repurchase program - Kodiak Gas Services announced that its Board of Directors has approved a share repurchase program, with authorization to purchase up to an aggregate of $50 million of the Company's common stock, commencing on the date thereof and expiring on December 31, 2025

15:33 EST Inno Holdings Inc trading halted, volatility trading pause

15:21 EST CEMIG trading resumes

14:48 EST Motorola Solutions increases regular quarterly dividend by 11% to $1.09 p/s - Motorola Solutions announced that its board of directors has increased its regular quarterly dividend by 11% to $1.09 per share. The next quarterly dividend will be payable in cash on January 15 , to stockholders of record at the close of business on December 13 .

14:34 EST Coherent Director Elizabeth Patrick sells $580K in shares - Coherent Director Elizabeth Patrick disclosed the sale of 5,542 shares of company stock $104.64 per share on November 13, for a total transaction amount of $579,910.

14:15 EST BE Semiconductor says no response to market rumors, committed to plan - BE Semiconductor Industries noted today recent media articles referring to a potential strategic combination involving the company. "Besi does not respond to market rumors. The company is fully committed to the execution of its strategic plan to enhance shareholder value as an independent company," Besi stated.

14:03 EST Treasury says MetLife unit to pay $178,421 to settle potential civil liability - American Life Insurance Company (ALICO), a Delaware subsidiary of MetLife, Inc. that offers group and individual insurance globally, has agreed to pay $178,421 to settle its potential civil liability for apparent violations of OFAC sanctions on Iran, the Department of the Treasury, Office of Foreign Assets Control, announced. Reference Link

13:58 EST Biglari says Cracker Barrel preliminary Q1 report 'reinforces our concerns' - Biglari Capital issued a response to Cracker Barrel Old Country Store's first quarter 2025 earnings announcement, stating in part: "Cracker Barrel's preliminary Q1 2025 earnings announcement reinforces our concerns that the Company is on the wrong track. The Company did not disclose the change in guest traffic, which continued to decline during the quarter. The adjusted EBITDA margin in Q1 2025 was 5.4%, 70 bps lower than in Q1 2023, and similar to that in Q1 2024. Considering FY 2024 was the worst year in Cracker Barrel's history, the fact that Q1 2025 results are comparable to Q1 2024 performance suggests that the transformation plan is not working. Importantly, Cracker Barrel did not change its FY 2025 guidance. Management expects revenue and adjusted EBITDA in FY 2025 to be similar to or lower than in FY 2024, assuming the midpoint of guidance, despite opening two new Cracker Barrel stores and three to four new Maple Street Biscuit units and making $160 million to $180 million in capital expenditures... The Q1 2025 results do not change the underlying concerns we have or the urgent need for change. Shareholders cannot afford to wait for the Company to implode. Cracker Barrel is in trouble if the incumbent Board is investing $180 million only to stay at par with FY 2024, which saw the worst performance in company history. Shareholders must act now to protect their investments."

13:33 EST Wellchange Holdings Co Ltd trading halted, volatility trading pause

13:19 EST Agrify Corp trading resumes

13:15 EST ELVA Stock trading resumes

12:53 EST Snapchat adds location sharing features to Family Center - Snap announced new new location sharing features coming to Family Center, Snapchat's in-app hub where it offers parental tools and resources. "Snapchat is already home to one of the most popular maps on mobile," the company said. "More than 350M people use our Snap Map every month to share their location with their friends and family to help stay safe while out and about, to find great places to visit nearby, and to learn about the world through Snaps from around the globe. Soon, new Snap Map location sharing features in Family Center will make it easier than ever for families to stay connected while out and about." Reference Link

12:33 EST Rivian, Lucid lower after Reuters says Trump to kill EV tax credit

12:16 EST ELVA Stock trading halted, news pending

12:00 EST Oscar Health rises 18.2% - Oscar Health is up 18.2%, or $2.46 to $15.94.

12:00 EST Ibotta falls -14.9% - Ibotta is down -14.9%, or -$11.19 to $63.74.

12:00 EST Zeekr falls -25.8% - Zeekr is down -25.8%, or -$7.50 to $21.64.

11:42 EST Capri says open to talks with companies interested in assets - Capri Holdings (CPRI) CEO says the company is well positioned to move ahead as an independent public company after Capri and Tapestry (TPR) mutually agreed that terminating the merger agreement was in the best interests of both companies. The CEO says the Michael Kors brand was not evolving as needed and sales have been impacted by a slowdown in luxury fashion goods globally as well as outsized weakness in China. The company intends to reduce expenses by closing unprofitable stores and additional workforce optimization. The company has been open to conversations with any company that has interest in any of its assets, Capri executives added. Comments from Capri's strategic update call following the announcement of the deal break.

11:25 EST Eisai receives positive CHMP opinion for Lecanemab in early Alzheimer's disease - Eisai (ESAIY) and Biogen (BIIB) announced that a positive opinion has been received from the Committee for Medicinal Products for Human Use of the European Medicines Agency recommending approval of the amyloid-beta monoclonal antibody lecanemab as a treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease who are apolipoprotein E non-carriers or heterozygotes with confirmed amyloid pathology. Eisai had requested a re-examination of the prior negative opinion adopted by the CHMP in July 2024. In accordance with European Medicines Agency regulatory process, the European Commission is expected to make a final decision on the marketing authorization application of lecanemab based on the CHMP recommendation within 67 days of receipt of CHMP opinion. Eisai serves as the lead for lecanemab's development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.

11:04 EST EMA recommends Leqembi for treatment of early Alzheimer's disease - The EMA stated: "After re-examining its initial opinion, EMA's human medicines committee, or CHMP, has recommended granting a marketing authorisation to Leqembi for treating mild cognitive impairment or mild dementia due to Alzheimer's disease in patients who have only one or no copy of ApoE4, a certain form of the gene for the protein apolipoprotein E. Patients with only one or no copy of ApoE4 are less likely to experience amyloid-related imaging abnormalities, or ARIA, than people with two ApoE4 copies. ARIA is a recognised serious side effect with Leqembi that involves swelling and potential bleeding in the brain. The CHMP concluded that, in the restricted population assessed in the re-examination, the benefits of Leqembi in slowing down progression of symptoms of the disease are greater than its risks. In July 2024, the Committee had issued a negative opinion on the use of Leqembi in a broader population of all patients with early Alzheimer's disease." Reference Link

10:34 EST Google to stop serving political advertising in EU ahead of regulation - Alphabet's Google said it will stop serving political advertising in the European Union ahead of new regulation in October 2025. Google said, "The European Union's upcoming Regulation on Transparency and Targeting of Political Advertising unfortunately introduces significant new operational challenges and legal uncertainties for political advertisers and platforms. For example, the TTPA defines political advertising so broadly that it could cover ads related to an extremely wide range of issues that would be difficult to reliably identify at scale. There is also a lack of reliable local election data permitting consistent and accurate identification of all ads related to any local, regional or national election across any of 27 EU Member States. And key technical guidance may not be finalized until just months before the regulation comes into effect. As a result, Google will stop serving political advertising in the EU before the TTPA enters into force in October 2025. Additionally, paid political promotions, where they qualify as political ads under the TTPA, will no longer be permitted on YouTube in the EU." Reference Link

10:24 EST Talen Energy: Susquehanna permitted to decrease amount of power supply provided - In a regulatory filing, Talen Energy (TLN) said that under a prior, FERC-accepted interconnection agreement between PJM, Susquehanna, and a subsidiary of PPL Corporation (PPL), Susquehanna is permitted to decrease by up to 300 MW the amount of power supply that it would otherwise provide to the power grid within PPL's service area. Susquehanna currently provides that power to load via load-owned transmission directly connected to Susquehanna rather than supplying load from the power grid. In June 2024, PJM filed at FERC an Amended Interconnection Service Agreement executed between the ISA Parties permitting Susquehanna to decrease by up to 480 MW the amount of power supply that it would otherwise provide to the power grid and now intends to sell to AWS instead. PJM previously concluded such increase in the amount of withheld power would have no reliability impacts on the grid. In June 2024, despite the Amended ISA being applicable solely to the PPL service area, Exelon Corporation (EXC) and AEP (AEP) filed a protest to the Amended ISA at FERC and raised generic issues involving the direct connection of load service to generators. FERC responded by issuing a deficiency letter in August 2024 seeking more information about the arrangement described in the Amended ISA and separately setting a Technical Conference for November 2024 to discuss broader issues related to (i) co-located load connected directly to generation; and (ii) emerging reliability issues resulting from the dramatic rise in data center demand for power. In September 2024, PJM provided a response to FERC's August 2024 deficiency letter on the Amended ISA and filed a Construction Service Agreement between the ISA Parties and Mid-Atlantic Interstate Transmission, LLC to facilitate certain network upgrades to ultimately accommodate a 960 MW decrease of power supply to the grid. Talen filed its own comments in September 2024 and written testimony in the Technical Conference proceeding in October 2024. Shortly after the conclusion of the FERC Technical Conference on November 1, 2024, FERC issued a 2-1 decision rejecting the Amended ISA. Talen may seek a rehearing of the FERC order within the 30-day deadline for such motions and, if necessary, file a subsequent appeal in a U.S. Court of Appeals. nder a prior, FERC-accepted interconnection agreement between PJM, Susquehanna, and a subsidiary of PPL Corporation ("PPL") (collectively, the "ISA Parties"), Susquehanna is permitted to decrease by up to 300 MW the amount of power supply that it would otherwise provide to the power grid within PPL's service area. Susquehanna currently provides that power to load via load-owned transmission directly connected to Susquehanna rather than supplying load from the power grid. In June 2024, PJM filed at FERC an Amended Interconnection Service Agreement ("Amended ISA") executed between the ISA Parties permitting Susquehanna to decrease by up to 480 MW the amount of power supply that it would otherwise provide to the power grid and now intends to sell to AWS instead. PJM previously concluded such increase in the amount of withheld power would have no reliability impacts on the grid. In June 2024, despite the Amended ISA being applicable solely to the PPL service area, Exelon Corporation and AEP filed a protest to the Amended ISA at FERC and raised generic issues involving the direct connection of load service to generators. FERC responded by issuing a deficiency letter in August 2024 seeking more information about the arrangement described in the Amended ISA and separately setting a Technical Conference for November 2024 to discuss broader issues related to (i) co-located load connected directly to generation; and (ii) emerging reliability issues resulting from the dramatic rise in data center demand for power. In September 2024, PJM provided a response to FERC's August 2024 deficiency letter on the Amended ISA and filed a Construction Service Agreement between the ISA Parties and Mid-Atlantic Interstate Transmission, LLC to facilitate certain network upgrades to ultimately accommodate a 960 MW decrease of power supply to the grid. Talen filed its own comments in September 2024 and written testimony in the Technical Conference proceeding in October 2024. Shortly after the conclusion of the FERC Technical Conference on November 1, 2024, FERC issued a 2-1 decision rejecting the Amended ISA. Talen may seek a rehearing of the FERC order within the 30-day deadline for such motions and, if necessary, file a subsequent appeal in a U.S. Court of Appeals.

10:16 EST Bellevue Life Sciences Acquisition Corp trading halted, volatility trading pause

10:13 EST Boehringer Ingelheim commits to Veeva Vault CRM - Veeva Systems announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to Veeva Vault CRM. Boehringer Ingelheim is seeking to expand on its existing Veeva Commercial Cloud solutions and its One Medicine and Amplify platforms, which connect development processes and data on Veeva Development Cloud.

10:10 EST Corvus Pharmaceuticals announces preclinical dataon soquelitinib - Corvus Pharmaceuticals announced new preclinical data highlighting the potential of soquelitinib, the Company's lead ITK inhibitor program, to prevent lung damage, inflammation and pulmonary hypertension caused by systemic sclerosis. Systemic sclerosis is an autoimmune disease characterized by inflammation, fibrosis, vascular damage and interstitial lung disease, with ILD and pulmonary hypertension being the major causes of death in these patients. The disease involves the activation of Th2 helper T cells and cytokines produced by these cells, including IL-4, IL-5 and IL-13. The researchers utilized a Fra-2 transgenic mouse model that encompasses many of the features of systemic sclerosis in humans, including spontaneous systemic inflammation and fibrosis in the lungs, skin and heart, which leads to pulmonary hypertension and ILD. These mice also exhibit an accumulation of Th2 helper T cells. The Fra-2 transgenenic mice were treated with oral soquelitinib for seven weeks, compared to control Fra-2 transgenic mice. Compared to the control, the mice treated with soquelitinib showed: Significant reduction in lung infiltration and fibrosis, assessed by histology; Significant improvement in clinical score, which measures disease severity; Reduced vascular smooth muscle hypertrophy, assessed by histology; Reduced right ventricular systolic blood pressure, consistent with improvement in pulmonary hypertension. These results were confirmed in a second model of pulmonary fibrosis using a bleomycin lung injury model. Treatment with soquelitinib showed reduced pulmonary fibrosis, and infiltration with Th2 helper T cells.

10:08 EST Cullinan Therapeutics to present preclinical data for CLN-978 - Cullinan Therapeutics will present new preclinical data for CLN-978, its novel CD19xCD3 T cell engager. These data and the study schema for a planned Phase 1b study in patients with moderate to severe systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology, ACR Convergence 2024, being held in Washington, D.C., November 14-19. These data will be shared in a poster presentation on November 16, 2024, 10:30 a.m.-12:30 p.m. Eastern Time. Cullinan will also have a Booth in the Exhibit Hall. CLN-978 Preclinical Data: New in vitro preclinical data show CLN-978 induced similar T cell activation, target B cell depletion, and cytokine production in human peripheral blood mononuclear cells derived from patients with SLE or rheumatoid arthritis as compared to healthy volunteers. These studies collectively suggest that the previously observed cytokine window observed in B-NHL model systems, potentially resulting in a broad therapeutic index, is expected to be preserved in SLE and RA patients. In October, Cullinan Therapeutics announced U.S. Food and Drug Administration clearance of an Investigational New Drug Application for its global Phase 1 clinical trial to evaluate CLN-978 for the treatment of patients with moderate to severe SLE to proceed in the United States. Cullinan previously announced Human Research Ethics Committee approval to initiate the global clinical trial in Australia. The trial will enroll patients with a Systemic Lupus Erythematosus Disease Activity Index score of eight or greater and who have had an inadequate response to at least two treatments, including one immunosuppressive or biologic standard-of-care agent. Part A is a dose escalation phase using a modified single-ascending dose design to determine a recommended target dose for further development. Part A is planned to explore target dose levels of 10, 20, 30, and 45 micrograms in a stepwise ascending fashion, enrolling at least three patients in each cohort. Dose levels above 10 mcg will incorporate a step-up dose of 10 mcg administered on Day 1 followed by administration of the higher cohort target dose on Day 8. Part B is a dose expansion phase which will explore two or more recommended dose schedules informed by data from Part A of the study. The primary objective of the study is to evaluate the safety of CLN-978 for treatment of active moderate to severe SLE. Secondary objectives include pharmacokinetics, B cell kinetics, immunogenicity, and clinical activity. Initial clinical data are expected in the fourth quarter of 2025.

10:06 EST LM Funding signs asset purchase agreement to acquire assets of mining site - LM Funding America announced the signing of an asset purchase agreement to acquire the business assets of a 15 MW mining site in Oklahoma from Tech Infrastructure JV I, a joint venture majority-owned by Arthur Inc., for $7.3 million. The Company currently operates 10 MW of machines actively mining Bitcoin at this site. The acquisition includes most of the business assets of the JV, which includes air-cooled GIGA containers, transformers, and related infrastructure. Upon closing, LM Funding will pay approximately $1.1 million and apply previously extended loans to the JV, totaling approximately $3.7 million in accrued principal and interest, as a credit towards the purchase price. The remaining $2.5 million will be held in escrow to ensure the timely completion of this acquisition, including the exit of a third-party miner currently hosted by the JV. At the signing of the asset purchase agreement, the Company lent an additional $0.7 million to JV, which resulted in aggregate loans totaling $3.7 million by the Company to the JV. The facility and assets are being acquired by LM Funding for its own internal hosting needs and not for the purpose hosting third-party mining machines. rthur Inc. emphasized the strategic importance of the transaction, noting that the proceeds will be reinvested directly into its subsidiary growth strategy, focusing on the development of new mining sites and the expansion of its operational capacity. Not later than January 2025, LM Funding plans to vacate the third-party miner currently hosted at the site from 5 MW of Arthur Mining's current hosting space, paving the way for the deployment of approximately 800 of LM Funding's S21 and XP Bitmain machines and 640 S19J Pros. The escrow is expected to be paid not later than January 2025 once all third-party miners are removed from the site and certain other closing conditions are met

10:03 EST Ambipar Emergency Response trading resumes

10:02 EST BTC Digital Ltd trading halted, volatility trading pause

10:00 EST ESS Tech falls -14.8% - ESS Tech is down -14.8%, or -$1.32 to $7.58.

10:00 EST Hims & Hers falls -17.7% - Hims & Hers is down -17.7%, or -$4.88 to $22.72.

10:00 EST Hillenbrand rises 12.8% - Hillenbrand is up 12.8%, or $3.85 to $34.02.

09:56 EST Zoomcar Holdings Inc trading resumes

09:51 EST Zoomcar Holdings Inc trading halted, volatility trading pause

09:48 EST Interactive Strength Inc trading resumes

09:47 EST BrightView falls -17.8% - BrightView is down -17.8%, or -$3.25 to $15.00.

09:47 EST Spire Global rises 11.5% - Spire Global is up 11.5%, or $1.55 to $15.00.

09:47 EST Beazer Homes rises 14.1% - Beazer Homes is up 14.1%, or $4.52 to $36.48.

09:46 EST Nuvectis Pharma Inc trading resumes

09:43 EST Interactive Strength Inc trading halted, volatility trading pause

09:42 EST Tilman Fertitta reports 9.9% passive stake in Wynn Resorts - Tilman Fertitta of Fertitta Entertainment reported holding a 9.9% passive stake in Wynn Resorts in a regulatory filing. Reference Link

09:41 EST Nuvectis Pharma Inc trading halted, volatility trading pause

09:41 EST Galaxy Payroll Group Ltd trading halted, volatility trading pause

09:40 EST Verizon Business enters partnership with Knightscope for connectivity - Knightscope (KSCP) announces a partnership with Verizon Business (VZ) to provide secure, reliable connectivity for the deployment of Knightscope's K5 security robots and K1 emergency communication devices to help elevate safety at commercial and government facilities.

09:38 EST Aligos Therapeutics trading resumes

09:37 EST PulteGroup raises quarterly dividend 10% to 22c per share - PulteGroup announced that its Board of Directors has voted to increase the company's quarterly cash dividend by 10% to 22c per common share. The increase will be effective with the company's next scheduled dividend, which is payable January 3, 2025, to shareholders of record at the close of business on December 17, 2024.

09:35 EST comScore trading halted, volatility trading pause

09:33 EST Aligos Therapeutics trading halted, volatility trading pause

09:32 EST Jet.AI Inc trading halted, volatility trading pause

09:29 EST Curtiss-Wright general counsel Paul Ferdenzi retires, George McDonald succeeds - Curtiss-Wright announced that Paul Ferdenzi, VP, general counsel and corporate secretary, plans to retire after a 25-year career with the company. Ferdenzi will continue to serve as a VP of the company to assist the executive team with the transition until his retirement at the end of this year. As part of its formal succession plan, the board of directors announced that, effective immediately, George McDonald has been promoted to VP, general counsel and corporate secretary, and has been named an officer of the company.

09:26 EST Lithium Corp. expands scope to evaluate opportunities in renewable energy - In a strategic move underscoring the Company's commitment to advancing electrification and a low carbon economy, Lithium Corporation is expanding its scope beyond mineral exploration to actively evaluating opportunities in renewable energy generation and energy storage. These closely related sectors are considered a natural extension to the Company's core interest in clean energy. Lithium Corporation's portfolio of critical mineral prospects includes several lithium prospects in Nevada, and titanium, rare earth elements, graphite and fluorspar properties in Canada. It reflects the Company's focus to-date on energy metals for the North American battery supply chain. The deep integration of renewable energy and energy storage systems with the battery supply chain prompted Lithium Corporation to look beyond mineral exploration, as the Company continually seeks to enhance its environmental stewardship and secure operational sustainability. Driven by a commitment to innovation, Lithium Corp. is exploring state-of-the-art, niche applications such as Agrisolar. Also known as agrivoltaics or dual-use solar, Agrisolar combines solar energy generation with agriculture. Crop or livestock production or pollinator habitats located underneath or adjacent to solar panels are examples of Agrisolar.

09:23 EST ZOOZ Power enters standby equity purchase agreement to further growth strategy - ZOOZ Power announced that it has entered into a Standby Equity Purchase Agreement with YA II PN, an investment fund managed by Yorkville Advisors Global, LP. This agreement aligns with ZOOZ's ongoing efforts to expedite growth and provides a flexible financing option to support future capital needs. "ZOOZ continues to gain industry recognition, as demonstrated by recent customer installations," said Avi Cohen, ZOOZ Power's Executive Chairman. "With this agreement, we have secured access to additional funding that can be deployed when and if needed. This strategic financing solution, as outlined in the SEC filing, provides ZOOZ with supplemental capital while allowing us to control the terms and timing of equity sales."

09:21 EST Jamf Holding achieves Microsoft Azure's IP co-sell top-tier partner status - Jamf (JAMF) announced their flagship device management solution Jamf Pro is now available on the Azure cloud, and both Jamf Pro and the Jamf bundled plans can be purchased in the Azure Marketplace. Jamf also announces it has achieved Microsoft (MSFT) Azure's IP co-sell top-tier partner designation which is the highest partnership level benefit in the Microsoft AI Cloud Partner Program. This recognition unlocks incentives for Microsoft sellers to team up with Jamf in providing joint solutions for shared customers, which now include the Jamf plugin for Microsoft Copilot for Security, announced as generally available today.

09:20 EST MiMedx provided update on LCDs regarding skin substitute - MiMedx provided the following update on the Local Coverage Determinations, LCDs, regarding "Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers." These new LCDs were originally proposed in April 2024, with a comment period that concluded in June 2024. The LCDs are now set to become effective on February 12, 2025. As a result of industry feedback, the final LCDs have been modified in the following key areas: The number of separate treatment applications a patient can receive was raised from 4 to 8; Treatment duration increased from 12 to 16 weeks; Importantly, the MACs have maintained their insistence on well-powered, peer-reviewed clinical evidence as a prerequisite for reimbursement.

09:19 EST Intuitive Machines delays next moon mission to February 2025 from January - Intuitive Machines discussed the moon mission planned timing on its Q3 earnings call.

09:18 EST Kloeckner invests in new aluminum processing facility - Klockner & Co will build a new aluminum flat-rolled processing facility on the campus of Aluminum Dynamics in Columbus. The investment is part of the ongoing implementation of the company's strategy whereby Klockner & Co is consistently expanding its product and service portfolio along the value chain for customers. As part of this strategy, Klockner & Co intends to broaden its toll processing portfolio to benefit from the profitable higher value-added business and from being significantly less dependent on steel price developments. The strategic investment, which will be realized through Klockner's US subsidiary Kloeckner Metals Corporation will enable Klockner & Co to accelerate the growth of its automotive and industrial segment in both important growth markets, the US as well as Mexico. Moreover, the investment will support the long-standing collaboration with ADL's parent company, Steel Dynamics. The new 200,000-square-foot facility has an annual capacity of up to 250,000 tons strategically located to process ADL's energy-efficient, CO 2 -reduced aluminum products. With its on-campus location, KMC will be able to offer highly sustainable, best-in-class aluminum processing solutions, leveraging a hub and spoke model utilizing the 55 locations across the KMC network in the US and Mexico. The new location, with ramp up planned for Q4 2026, offers room for growth to add additional higher value-added processing services to meet the growing market demand for laser blanking.

09:16 EST Norfolk Southern reaches agreement with Ancora to add new Board director - Norfolk Southern has entered into a cooperation agreement with Ancora under which Norfolk Southern and Ancora will work together to identify an independent director to join the company's Board of Directors. The addition of the new director, who is expected to enhance the Board's gender diversity and executive leadership experience, will expand Norfolk Southern's Board to 14 members, including 13 independent members. Pursuant to the cooperation agreement, Ancora has agreed to withdraw its nomination of four director candidates for election at the Norfolk Southern 2025 Annual Meeting of Shareholders. Ancora has also agreed to vote in accordance with the Board's recommendations in connection with any vote of Norfolk Southern shareholders, including at the 2025 Annual Meeting, and to a standstill provision.

09:15 EST U.S. Navy awards Comtech $5M SLM-5650B modem contract - Comtech Telecommunications announced that the U.S. Navy Information Warfare Systems Command awarded the Company a sole source contract for Comtech's U.S sovereign software-defined SLM-5650B satellite communication or SATCOM modems, upgrade kits, firmware options and technical support. The contract has a four-year period of performance and is valued in excess of $50.0 million. Funded orders received to date are valued at approximately $2M...."As data rate demands in the U.S. Navy Fleet increase, and satellite technologies evolve to provide enhanced capabilities, Comtech's U.S. sovereign SLM-5650B modems are uniquely designed to meet the needs of the Navy today, as well as the joint force operations of tomorrow," said John Ratigan, President and CEO of Comtech. "As a longstanding trusted partner of the U.S. Navy, Comtech's modem technologies provide critical communications capabilities that enhance situational awareness and improve operational effectiveness in the world's most challenging environments. We are honored to strengthen our relationship with the U.S. Navy through this award, which provides a new contracting vehicle to significantly expand the number of Comtech SATCOM modems delivered over the next four years."

09:13 EST Planet Labs expands contract with French digital farming company Abelio - Planet Labs PBC announced that it has signed an expansion with their partner Abelio, a French technology company offering smart farming solutions. Abelio leverages the Planet Insights Platform and the company's PlanetScope satellite data to enhance their digital agriculture solutions. Through this expansion, Abelio will have access to agricultural data across France - nearly three times the amount of Planet data that it previously integrated into its solutions in 2023..."We are very excited by this expansion with Abelio. With increased access to our satellite data, they can continue to strengthen their models and offer broader locations for customers," said Planet President Ashley Johnson. "With growing food demands and increased sustainability regulations, having advanced solutions for precision agriculture is critical for the 21st century." .."We have a farmer-first approach at Abelio, and that means that we also look to deliver the most timely and detailed data into our agronomic solutions," said Samuel Bonnard, Head of International Business Development at Abelio. "Our work with Planet has let us smoothly analyze valuable near-real-time data streams and scale our solutions just over a few years." Abelio has worked with Planet data and products since 2018, building their solutions with the Planet Insights Platform technology.

09:12 EST Thumzup accelerates expansion across the greater Los Angeles area - Thumzup Media announce an ambitious expansion plan aimed at significantly growing its presence throughout the greater Los Angeles region. The Company, which has been primarily focused on the west side of Los Angeles, is aggressively expanding into new areas. Following the Company's successful Nasdaq listing and $8.2 million dollar underwritten offering, Thumzup is leveraging new resources to accelerate growth and connect more businesses with local communities through its innovative user-generated advertising approach.

09:11 EST AIM ImmunoTech stockholder Kellner Group issues letter on Board vote - AIM Immunotech stockholder Ted Kellner, as the nominating stockholder and a nominee, together with his other nominees, issued a statement in connection with the incumbent Board of Directors of AIM Immunotech. The statement includes, among things, the following: "the Delaware Supreme Court ruled that the incumbent Board breached its fiduciary duties to stockholders"; "the AIM Board wasted millions in furtherance of improper purpose"; "stockholders are urged to act now before the Board's self-interested behavior irreversibly damages the company"; "stockholders should not be fooled by misleading statements by AIM Board"; "Kellner Group nominees bring skills, experience and credibility necessary for AIM to be successful"; " Based on AIM's own disclosures, we estimate that the incumbent Board has spent between $15.0M to $20.0M in just the past two years in their bad faith effort to prevent a meaningful election of directors and maintain control"; "All of the incumbent Board members bear responsibility and must be held accountable"; "The incumbent Board's primary argument for its election - suggesting that the Kellner Group includes criminals - is completely and demonstrably false"; "The incumbent Board's breach of fiduciary duties, gross waste and lack of transparency are disqualifying".

09:10 EST Tigo Energy wins patent dispute for intellectual property - Tigo Energy announced a legal victory in defense of its core intellectual property. The U.S. Patent and Trademark Office, or USPTO, has rejected SMA Solar Technology AG's challenge to Tigo U.S. Patent No. 9,584,021, which covers a power-supply design for module-level power electronics technology that addresses false-start problems when solar systems are powering up. The company said, "This latest USPTO ruling follows others that have served to solidify the portfolio of intellectual property Tigo has developed through investment in research and development. The decision also marks a further win in a series of disputes with SMA, in which Tigo has successfully defended patents integral to its MLPE technology, including U.S. Patent Nos. 9,966,848 and 10,333,405. These three patents are part of Tigo's ongoing patent-infringement dispute with SMA in the U.S. District Court for the District of Delaware."

09:09 EST Beyond Meat's Beyond Sun Sausage expands to whole foods market - Beyond Meat announced that its newest product innovation, Beyond Sun Sausage, is rolling out at Whole Foods Market stores across the country. The expansion follows an initial successful launch in late July, with the Beyond Sun Sausage brand line quickly becoming a top selling new plant-based meat product in natural grocery retailers. Unlike Beyond Meat's core product portfolio, Beyond Sun Sausage is not intended to replicate beef, pork or poultry but rather be its own satisfying protein option. Made from wholesome plant-based ingredients, including spinach, bell peppers and yellow pea, brown rice and red lentil proteins, Beyond Sun Sausage is available in culinary-forward flavors with Beyond Sun Sausage Pesto rolling out now at all Whole Foods Stores nationwide, and Beyond Sun Sausage Cajun rolling out at select Whole Foods Stores coast-to-coast.

09:06 EST 374Water, Inc. releases white paper showcasing AirSCWO technology - 374Water released a white paper showcasing its AirSCWO technology's successful lab and commercial-scale tests in the destruction of Aqueous Film-Forming Foam. AFFF, widely used throughout the firefighting industry, contains per- and polyfluoroalkyl substances, a group of persistent and potentially hazardous chemicals that pose risks to human health and ecosystems. Over 99.99% of PFAS compounds were destroyed within seconds in the Company's tests, positioning 374Water's AirSCWO technology as a potential leading, environmentally safe solution to complete commercial-scale destruction of AFFF and related PFAS compounds. White Paper Highlights: AFFF, a synthetic firefighting agent, is widely employed by government, municipal, and industrial fire safety teams for rapid suppression of liquid fuel fires. Since the 1960s, its extensive use in high-risk settings like military bases, airports, and chemical plants has led to significant PFAS contamination of soil and water. Increasingly stringent environmental and health regulations are driving the phase-out of PFAS-containing AFFF, with requirements for safe disposal to prevent further contamination. For instance, the U.S. National Defense Authorization Act for 2020 mandates a DoD transition to fluorine-free AFFF alternatives by October 2024. Additionally, U.S. states are implementing AFFF buy-back programs, and the EU's 2024 regulation enforces phased restrictions on PFAS in firefighting foams for public and aviation sectors. 374Water's AirSCWO technology leverages supercritical water oxidation to destroy organic waste, producing only clean water, mineral effluent, and recoverable heat. In multiple lab and commercial-scale tests, AirSCWO consistently achieved greater than99.99% destruction of AFFF, transforming complex waste into inert by-products. AirSCWO offers a timely, scalable solution for government and industrial partners seeking reliable, high-throughput PFAS disposal.

09:04 EST PHX Minerals issues negative response to WhiteHawk acquisition proposal - PHX Minerals responded to the WhiteHawk Energy proposal to acquire PHX: "The PHX Board of Directors appreciates engagement from all stockholders to enhance stockholder value. We and PHX management continue to review opportunities that are focused on maximizing stockholder value. With respect to the WhiteHawk proposal, as we communicated to WhiteHawk, the Board of Directors of PHX believes it is in the best interest of the company's stockholders to decline this proposal".

09:00 EST Disney says does not see value in spinning off, selling TV assets - Says "doesn't need" to acquire content, distribution via M&A.

08:58 EST LPL Financial: Prosperity joins LPL's broker-dealer, RIA, custodial platforms - LPL Financial LLC, announced today that the financial advisors at Prosperity Investment Management have joined LPL Financial's broker-dealer, RIA and custodial platforms. They reported having approximately $140 million in advisory, brokerage and retirement plan assets and join LPL from Osaic. Based in a renovated historic building in downtown Chico, Calif., Prosperity Investment Management was founded by seasoned financial advisor Robert "Rob" B. Anderson, CFP. His son, RJ Anderson, CPA, joined the business in 2020 following an initial career in accounting and now leads the firm as a financial advisor. They offer a broad spectrum of financial services to individuals and business owners, including investment management, financial planning, retirement planning and estate planning.

08:56 EST Barnes & Noble College to partner with North Carolina A&T - Barnes & Noble College, a Barnes & Noble Education, announced it will partner with North Carolina Agricultural and Technical, N.C. A&T, State University to manage the N.C. A&T Bookstore, transitioning store operations in November. Recognizing Barnes & Noble College's outstanding product assortment, customer experience and support, N.C. A&T has chosen to end its relationship with its previous provider and partner again with BNC as its exclusive campus retail partner. BNC's strategic vision and approach better align with N.C. A&T's mission to deliver a high-quality and affordable education that will support student academic success and instill Aggie Pride.

08:54 EST Charles Schwab:Total client assets $9.85T at October-end up 29% YoY - The Charles Schwab Corporation released its Monthly Activity: Report today. Company highlights for the month of October 2024 include:Core net new assets brought to the company by new and existing clients totaled $24.6B. Net new assets excluding mutual fund clearing totaled $21B. Total client assets equaled $9.85T as of month-end October, up 29% from October 2023 and down 1% compared to September 2024.

08:52 EST Sky Quarry near completion of first wave of asphalt shingle modular facility - Sky Quarry announced construction of its first Waste Asphalt Shingle Modular Facility, designed to process waste asphalt shingles in regional markets, is currently 80% complete. Completion of the first Waste Asphalt Shingle Modular Facility will mark a critical milestone in Sky Quarry's mission to transform millions of tons of waste shingles headed to U.S. landfills into valuable, reusable resources. The final fabrication and mechanical updates are scheduled alongside the retrofitting at the PR Spring extraction facility in Utah, with operations expected to commence in 2025, upon the completion of required project financing.

08:52 EST SAIHEAT to announce SAIHEAT Base Plan 2029 - SAIHEAT is pleased to unveil the SAIHEAT BASE PLAN 2029, an ambitious initiative delivering integrated energy services for the nextgen data centers. Addressing the high energy demands and carbon footprint of data centers, the BASE Project combines cutting-edge technologies for sustainable power generation, efficient energy usage, and comprehensive heat recycling in every step. The BASE PLAN 2029 embodies SAIHEAT's commitment to Energy Defined Nextgen Computing Centers, emphasizing renewable nuclear energy sources, efficient chip performance, and advanced energy recycling. Through the plan 2029, SAIHEAT aims to establish new standards in energy sustainability, operational resilience, and environmental responsibility, driving the future of high-performance, sustainable computing. In the BASE PLAN 2029, SAIHEAT features itself with two core business modules: HEATWIT - The thermal module that provides advanced liquid cooling systems and solutions for computing heat recycling, which is increasingly crucial as BTC and AI applications grow in demand and complexity. HEATWIT's technology includes high-efficiency cooling units and modular liquid-cooled cabinets, reducing carbon emissions and minimizing environmental impact. HEATNUC - The power module focuses on global power resource development and modular nuclear power joint development. HEATNUC integrates sustainable land-based Small Modular Reactor solutions and is planning to explore space-based solar energy systems, essential for the robust energy infrastructure required by data centers. Under the BASE PLAN 2029, SAIHEAT announces two exciting initiatives to tackle current energy source challenges. SAIHEAT will closely work with partners and jointly build development efforts by committing as a sponsor and key contributing member of non-profit group, Organization of Clean Energy and Climate. OpenSMR - An open-source initiative supporting AI-driven data centers with SMR technology, OpenSMR aims to provide standardized, cost-effective energy models for the computing industry. In alignment with OpenSMR's mission, SAIHEAT will release key patents to advance SMR adoption in data centers worldwide. These include: Control Rod Drive Mechanism for Small Modular Pressurized Water Reactors: This patent introduces a compact control rod drive mechanism enabling precise reactor control under extreme conditions. Containment Cooling Device and Method Utilizing Heat Pipe Cooling: This passive cooling system for SMRs utilizes heat pipes for efficient, reliable heat transfer without external power. OrbitBTC - OrbitBTC addresses the sustainability challenges of computing by relocating mining operations to space. Utilizing uninterrupted solar energy in orbit, OrbitBTC's mining rigs eliminate reliance on terrestrial grids, significantly reducing carbon emissions, water usage, and land impact. This innovative, space-based model offers a 24/7 renewable energy source, lowers operational costs, and provides scalable operations free from regulatory land constraints, setting a new benchmark for eco-friendly cryptocurrency mining.

08:50 EST iCoreConnect announces new endorsement agreement with NDDA - iCoreConnect has announced a new endorsement agreement with the North Dakota Dental Association, NDDA. The NDDA's endorsement adds them to a growing list of state dental associations backing iCoreConnect's full suite of innovative cloud solutions tailored for the dental industry. With over 180 product endorsement agreements across the U.S., iCoreConnect continues demonstrating its commitment to improving workflow efficiency, productivity, and data security in dental practices nationwide

08:49 EST Kaixin explores strategic alternatives with potential crypto mining acquisition - Kaixin Holdings announced a major strategic step forward as it explores new growth avenues. In the advanced stages of evaluating strategic alternatives, Kaixin is actively considering the acquisition of a controlling equity interest in a leading cryptocurrency mining company based in the Middle East. This mining company operates with cost-efficient BTC mining machines, optimizing self-mining processes while also offering sophisticated, end-to-end cloud hosting services tailored to meet the growing demand within the crypto mining industry. The facility's long-term, stable energy supply is a critical asset that bolsters operational resilience and cost efficiency, underscoring Kaixin's commitment to sustainable and profitable growth.

08:47 EST MSA Safety awarded $33M breathing apparatus contract with U.S. Coast Guard - MSA Safety has been awarded a multi-year $33M contract with the U.S. Coast Guard to provide new firefighter respiratory protective equipment. Initial orders under the contract, valued at approximately $22M, were received in Q3. Production of the new U.S. Coast Guard breathing apparatus units is underway at the company's Murrysville, Pennsylvania, manufacturing facility.

08:46 EST Disney says ESPN flagship will be 'best product' in sports video - Says "optimistic" on parks bookings in 2H25.

08:44 EST Disney says Q1 to be 'negatively impacted' by two hurricanes in Florida

08:44 EST Safety Shot now available at 300 locations of grocery chain - Safety Shot, Sure Shot, now available in a convenient 4 oz. bottle at over 300 locations of the grocery chain recently voted "Best Grocery Store in America" by USA Today readers in their annual 10Best Readers' Choice Awards. This leading Midwestern retailer is renowned for its commitment to customer satisfaction and extensive product selection.

08:39 EST Rexford Industrial provides operating activity update - Rexford Industrial provided an operating activity update. In Q4 to date, Rexford Industrial executed approximately 657,000 square feet of new and renewal leases, with an average size of 16,000 square feet, including approximately 422,000 square feet of renewal leases and 235,000 square feet of new leases. Comparable rental rates on new and renewal leases increased by 80% compared to prior rents on a net effective basis and by 60% on a cash basis. Average annual rent steps were 3.9% for leases executed quarter to date. As of October 31, year-to-date Same Property Portfolio average occupancy was 96.8% and ending occupancy was 95.9%, in line with Q3 guidance.

08:39 EST Gabelli Global Multimedia Fund reaffirms 10% distribution policy - The Board of Directors of The Gabelli Multimedia Trust reaffirmed and satisfied its 10% distribution policy by declaring a $0.22 per share cash distribution payable on December 20, 2024 to common stock shareholders of record on December 13, 2024. With this fourth quarter distribution, the total distributions from the Fund for 2024 would equate to $0.88 per share. The Fund intends to pay a minimum annual distribution of 10% of the average net asset value of the Fund within a calendar year or an amount sufficient to satisfy the minimum distribution requirements of the Internal Revenue Code for regulated investment companies. Each quarter, the Board of Directors reviews the amount of any potential distribution from the income, realized capital gain, or capital available. The Board of Directors will continue to monitor the Fund's distribution level, taking into consideration the Fund's net asset value and the financial market environment. The Fund's distribution policy is subject to modification by the Board of Directors at any time, and there can be no guarantee that the policy will continue. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.

08:36 EST Gabelli Equity Trust reaffirms 10% distribution policy - The Board of Directors of The Gabelli Equity Trust reaffirmed and satisfied its 10% distribution policy by declaring a $0.15 per share cash distribution payable on December 20, 2024 to common stock shareholders of record on December 13, 2024. With this fourth quarter distribution, the total distributions from the Fund for 2024 would equate to $0.60 per share. The Fund intends to pay a minimum annual distribution of 10% of the average net asset value of the Fund within a calendar year or an amount sufficient to satisfy the minimum distribution requirements of the Internal Revenue Code for regulated investment companies. Each quarter, the Board of Directors reviews the amount of any potential distribution from the income, realized capital gain, or capital available. The Board of Directors will continue to monitor the Fund's distribution level, taking into consideration the Fund's net asset value and the financial market environment. The Fund's distribution policy is subject to modification by the Board of Directors at any time, and there can be no guarantee that the policy will continue. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.

08:34 EST Nano Dimension urges shareholders to vote for company proposals - Nano Dimension sent a letter to its shareholders in connection with the Company's upcoming 2024 Annual General Meeting of Shareholders. The letter details the progress Nano has made in delivering on its promises to shareholders over the past year, including the execution of transformational M&A agreements designed to deliver scale with notable synergies and a clear path to profitability. In connection with the Annual Meeting and its letter to shareholders, the Company also released a video from CEO Yoav Stern highlighting Nano's focused value creation strategy and the progress the Company has made over the past 12 months. The video can be viewed at www.ProtectingNanoValue.com. Nano's Board of Directors urges shareholders to protect their investment and the Company's future by voting today "FOR" ALL of Nano's proposals. Votes must be received by 11:59 P.M. ET on Sunday, December 1st, 2024. Shareholders of record as of the close of business on October 22nd, 2024, are entitled to vote at the Annual Meeting. The Annual Meeting will be held on Friday, December 6th, 2024, at 7:00 A.M. ET.

08:33 EST WTW appoints Tyler Adkerson as growth leader, PE&TS - WTW announced the appointment of Tyler Adkerson as Growth Leader for Private Equity and Transactional Solutions, Corporate Risk and Broking, North America. In his new role, Adkerson will develop and execute strategic client initiatives to strengthen partnerships with key stakeholders in Mergers and Acquisitions. Leveraging the subject-matter expertise of WTW's Industry Vertical Divisions, Adkerson will drive PE&TS growth efforts including developing solutions to assist WTW clients navigate and mitigate the most complex risk issues in the M&A space. Additionally, he will lead the formation of a client advisory board to bring emerging trends, questions, and issues directly from clients into the PE&TS industry vertical's solutions ideation process, further cementing WTW's client-focused approach. With more than 20 years of industry experience, Adkerson joins WTW from Aon, where he most recently served as the Global Co-Head for Corporate Client M&A and Professional Advisory Coverage for the M&A Transaction Solutions team.

08:32 EST Microchip releases PolarFire FPGA Ethernet Sensor Bridge - To enable developers building artificial intelligence-driven sensor processing systems, Microchip Technology has released its PolarFire FPGA Ethernet Sensor Bridge that works with the NVIDIA Holoscan sensor processing platform. PolarFire FPGAs enable multi-protocol support, and this first solution to be released as part of Microchip's platform is compatible with MIPI CSI-2-based sensors and the MIPI D-PHYSM physical layer. Future solutions will support a wide range of sensors with different interfaces, including SLVS-EC(TM) 2.0, 12G SDI, CoaXPress 2.0 and JESD204B. The platform allows designers to leverage the power of the NVIDIA Holoscan ecosystem while taking advantage of the PolarFire FPGA's power-efficient technology with low-latency communication and multi-protocol sensor support.

08:30 EST Rego Payment Architectures collaborates with Jack Henry - Rego Payment Architectures announced that its leading white-label youth banking solution is now accessible through the Jack Henry digital banking platform. REGO leveraged the Banno Digital Toolkit, the same set of APIs the Banno Digital Platform is built on, to embed its technology into the digital experiences offered by community and regional financial institutions. Access to Jack Henry's API, design, and authenticated frameworks has enabled REGO to directly integrate into the digital banking platform providing a seamless banking experience. This integration contributes to Jack Henry's growing ecosystem of over 1,000 fintechs, providing approximately 7,500 financial institutions with relevant financial products and services for their accountholders.

08:27 EST Dillard's launches Lilly Sisto for Gianni Bini - Dillard's announced the launch of Lilly Sisto for Gianni Bini. This exclusive line of contemporary apparel, footwear, handbags and accessories is a limited-edition capsule collection designed in collaboration with New York-based fashion tastemaker, Lilly Sisto. The collection is now available for a limited time in Dillard's stores across the nation as well as online at dillards.com.

08:24 EST Digihost releases updated investor presentation - Digihost Technology announced that the company will provide a summary of the Company's unaudited financial results for the third quarter ended September 30, 2024 and a 2024 year-to-date update on its operations before market open on November 15, 2024. Additionally, The company will host a conference call to discuss third-quarter 2024 results on November 15, 2024, at 8:30 AM ET. Digihost's executives will review the Company's financial results for 3Q24 and provide more updates on the company's state.Additionally, the company has released a new investor presentation in anticipation of the call, which will be referenced during the earnings call on November 15th.

08:24 EST ALX Oncology appoints Alan Sandler as CMO - ALX Oncology Holdings announced the appointment of Alan Sandler, M.D., as Chief Medical Officer. He previously held the position of Executive Vice President, Chief Medical Officer at Mirati Therapeutics, prior to its acquisition by Bristol Myers Squibb in early 2024.

08:22 EST Windtree Therapeutics announces CEO Fraser to retire, Latkin to succeed - Windtree Therapeutics announced that Craig Fraser plans to retire from his role as Chief Executive Officer, effective December 1, 2024, after nearly nine years of distinguished service to the Company. Mr. Fraser will remain on the Board of Directors of the Company as Chairman. The Company's Board has appointed Jed Latkin, a current director of the Company, to replace Mr. Fraser as CEO and Mr. Latkin will also remain a member of the Board.

08:21 EST Yoshitsu launches online platform for Reiwatakiya brand in Canada - Tokyo Lifestyle announced the launch of a new online sales platform for its Reiwatakiya brand in Canada. The platform will serve as a one-stop online hub for North American customers, offering authentic Japanese health, beauty, and lifestyle products with local shipping options across North America. This launch represents a major milestone in the Company's regional expansion strategy.

08:19 EST Ageagle Aerial Systems secures 17 new purchase orders for eBee TAC drones - AgEagle Aerial Systems announces it has secured 17 new purchase orders for eBee TAC drones from U.S. defense and security customers. Delivery of the 17 eBee TAC systems is expected to occur by the end of November.

08:17 EST IBM to become UFC's official global AI partner - IBM (IBM) and UFC, the world's premier mixed martial arts organization and part of TKO Group Holdings (TKO), announced an innovative new partnership that will combine the power of IBM's AI and data platform, watsonx, with the vast global reach of UFC's content platforms to enhance the viewing experience for millions of UFC fans around the world. With the new agreement, IBM will become UFC's Official Global AI Partner, marking the first time UFC has opened up this marketing category to a brand partner. The core of the partnership will feature UFC Insights Engine built with IBM watsonx. Insights Engine will harness IBM's expertise in data and AI technologies - including its family of Granite large language models - and UFC's rich data feeds to provide the UFC global viewing audience with more timely, in-depth information. This includes unique insights and advanced analysis of live bouts, fighter tendencies, projections of possible match outcomes, and method of victory - all of which will be engineered to update in real-time on-screen as more live data is generated.

08:16 EST Cue names Daniel Baker interim CDO, CSO Amish Suri to transition to advisor role - Cue Biopharma announced that Daniel Baker, M.D., will join Cue Biopharma as interim chief development officer effective November 25, 2024. Dr. Anish Suri will transition from his current role of president & chief scientific officer and will serve the company as principal research and immunology advisor effective as of the same date. Following his retirement from Janssen in 2019, Dr. Baker served as CEO and founder of Kira Therapeutics and more recently as Executive Director on the board of Galapagos Therapeutics from April 2022 until October 2024.

08:12 EST Candel Therapeutics sees cash runway to end of 1Q25 - Cash and cash equivalents, as of September 30, 2024, were $16.6 million, as compared to $35.4 million as of December 31, 2023. Based on current plans and assumptions, the Company expects that its existing cash and cash equivalents will be sufficient to fund its current operating plan to the end of the first quarter of 2025.

08:09 EST RenovoRx reports Q3 net loss $2.5M vs $1.4M last year - Cash and cash equivalents as of September 30, 2024, were $9.6 million. "We made significant progress in the third quarter of 2024 towards our goal of patient enrollment completion of our pivotal Phase III TIGeR-PaC clinical trial in locally advanced pancreatic cancer, which is expected in the first half of 2025," said Shaun Bagai, CEO of RenovoRx. "In parallel, we have made important headway on commercialization plans for our FDA-cleared RenovoCath delivery system, creating the potential for near-term revenue generation."

08:06 EST Curis sees cash and cash equivalents sufficient into mid-2025

08:04 EST AAR Corp. signs exclusive global distribution agreement with Whippany Actuation - AAR Corp. (AIR) has signed an exclusive multi-year distribution agreement with Whippany Actuation Systems, a TransDigm Group (TDG) business. The agreement includes the global distribution of all components and sub-assemblies in Whippany's actuation product line and expands AAR's product offerings on key platforms, including Boeing 737 and 777. AAR's distribution services will compress lead times, add stocking locations, and enhance customer service for Whippany end users.

08:02 EST Galectin Therapeutics sees cash runway through May 2025 - As of September 30, 2024, the Company had $27.1 million of cash and cash equivalents. Additionally, the Company has $6 million available under a new line of credit provided by its chairman of the board to fund operations. The Company believes it has sufficient cash to fund currently planned operations and research and development activities through May 2025.

07:53 EST Stack Capital announces normal course issuer bid - Stack Capital Group announced that the Toronto Stock Exchange has accepted a notice filed by Stack Capital of its intention to make a normal course issuer bid with respect to its outstanding common shares. Stack Capital management believes its share price is undervalued compared to its recently announced Book Value per Share of $11.05. The notice provides that Stack Capital may, during the 12-month period commencing November 18, 2024, and ending no later than November 17, 2025, purchase through the facilities of the TSX and/or alternative Canadian Trading Systems up to 531,000 common shares in total, being 5.0% of the issued and outstanding common shares as of November 11, 2024. The price which Stack Capital will pay for any common shares will be the market price at the time of acquisition. During the period of this NCIB, Stack Capital may make purchases under the NCIB by means of open market transactions. The actual number of common shares which may be purchased pursuant to the NCIB and the timing of any such purchases will be determined by senior management of Stack Capital. The average daily trading volume from May 1, 2024 to October 31, 2024 was of 4,613 common shares. Daily purchases under the NCIB will be generally limited to 1,153 common shares, other than block purchases. All shares purchased by Stack Capital under the NCIB will be cancelled. As of November 11, 2024, there were 10,636,908 common shares of Stack Capital outstanding, and the public float was 8,213,866 common shares. Stack Capital may purchase its common shares, from time to time, if it believes that the market price of its common shares is attractive and that the purchase would be an appropriate use of corporate funds and in the best interests of Stack Capital.

07:50 EST Bel Fuse closes majority stake acquisition of Enercon - Bel Fuse announced that it has closed the previously announced majority stake acquisition of Enercon Technologies, from Fortissimo Capital based on an enterprise value of $400 million. Bel has acquired an 80% stake upfront for $320 million, plus up to $10 million of potential earnout payments for the 2025-2026 period, with the intent to purchase the remaining 20% by early 2027 based on future EBITDA performance. The transaction was funded through utilization of cash on hand of approximately $80 million, with approximately $240 million provided through incremental borrowings under the Company's revolving credit facility.

07:49 EST Dorel Industries anticipates 'continued strong performance' in Juvenile segment - "As we look ahead, Dorel Juvenile remains committed to driving sustainable growth through strategic investments in product innovation, continued market share gains and operational efficiency. We anticipate continued strong performance in our key markets, supported by our robust e-commerce channels and successful partnerships with key suppliers and retailers. Despite potential challenges from currency fluctuations and container costs, we are confident in our ability to navigate these headwinds and deliver sequential earnings improvement for the fourth quarter," commented Dorel President & CEO, Martin Schwartz. "Dorel Home is on a path to reduce its costs and match its footprint to current revenue expectations, which are substantially lower than our peak years of 2020 and 2021. We have expanded our restructuring plan announced at the end of 2023 with the consolidation of our RTA facilities in the third quarter and will be initiating other aggressive actions by the end of the year to right-size the business. We acknowledge that we are operating within a challenging industry, but we believe we can operate profitably with our dual sourcing business model of efficient domestic production coupled with overseas imports. With our recent success at major brick-and-mortar retailers and traditional leadership in e-commerce, we will focus on key profitable categories and targeted promotional activities. We remain confident in our ability to adapt to market conditions and deliver value to our shareholders," concluded Mr. Schwartz.

07:47 EST Relmada Therapeutics initiates Phase 1 dosing with REL-P11 - Relmada Therapeutics announced the initiation of dosing in a Phase 1 SAD study of REL-P11, an investigational agent for metabolic disease. "Dosing of the first subjects in the Phase 1 study is an important milestone for REL-P11, a low-dose, modified-release psilocybin formulation. Preclinical rodent studies, published at the American Association for the Study of Liver Disease in 2023, showed that treatment with REL-P11 improved multiple metabolic parameters with no detrimental CNS effects, and suggest that REL-P11 could have potential to become a valuable therapeutic option in the evolving obesity and metabolic syndrome space," said Sergio Traversa, Chief Executive Officer of Relmada. "We expect the Phase 1 study to help define the pharmacokinetic, safety and tolerability profile of REL-P11 and, with positive data, pave the way for a Phase 2a proof-of-concept study to begin in H1 2025."

07:45 EST Goodfood Market acquires controlling interest in Genuine Tea - Goodfood Market announced its acquisition of an 81% interest in Genuine Tea, a leading Canadian craft tea company. The founding shareholders of Genuine Tea will continue to lead the business and hold the remaining shares of the company, with Goodfood having a right to acquire their shares in the future. The acquisition, financed mainly with Goodfood's cash reserves, includes future performance-based payment features to the Genuine Tea shareholders. "We have grown Genuine Tea from a farmers' market venture to a multi-million-dollar national brand and we could not be happier to join the Goodfood family to propel Genuine Tea to the next level," said Sarah Wilcox, cofounder and CEO of Genuine Tea. Genuine Tea had over $3.5 million dollars of net sales in its most recent Fiscal year and the acquisition will be accretive to Goodfood's Adj. EBITDA margin. This acquisition marks the beginning of Goodfood's next chapter, focusing on building a portfolio of direct-to-consumer food and beverage brands. Having helped pioneer meal-kits for millions of Canadians, Goodfood now leverages its direct-to-consumer infrastructure, technology, and culinary expertise to empower select founders with a unique offering to expand and scale their businesses. As part of this acquisition, Genuine Tea's premium tea varieties will also be available through Goodfood's meal kit subscriptions, bringing added convenience and quality to Canadian consumers.

07:44 EST Skye Bioscience achieved more than 50% targeted patient enrollment in CBeyond - Skye Bioscience announced that it has achieved more than 50% of targeted patient enrollment for its CBeyond Phase 2 clinical trial assessing nimacimab, a differentiated CB1 inhibitor, in patients with overweight or obesity. Skye expects to report interim data for the CBeyond Phase 2 clinical trial in Q2 2025 after this initial set of enrolled patients has completed the 26-week treatment period. "We are grateful for the amazing motivation and responsiveness shown by our study participants and clinical investigators in the assessment of this first-in-class drug candidate for weight loss. The current pace of patient enrollment may also shorten our timeline to topline data next year. We will provide a further update after reaching full enrollment," said Puneet Arora, MD, Skye's Chief Medical Officer. "This is a rigorous clinical trial evaluating multiple important parameters. We look forward to advancing nimacimab through this program and getting this Phase 2 data next year."

07:41 EST Cibus completed edits in Canola for 4th mode of action - Cibus announced that it has successfully completed edits in Canola for its 4th mode of action for its Sclerotinia resistance trait and expects greenhouse results in the first quarter of 2025. Multiple modes of action, which are akin to a plant's defenses to disease, are critical for durable disease resistance. This advancement builds upon the Company's previously announced field trial results for its 2nd mode of action showing enhanced resistance to Sclerotinia in Canola plants edited with Cibus' Sclerotinia resistance trait.

07:40 EST Captivision announces venture with digiLED, Canary Wharf Group - Captivision announced a venture with digiLED, a leading LED innovator and solution provider, and Canary Wharf Group, CWG, to enhance Canary Wharf's transformation from a world-class financial center into a thriving mixed use neighborhood. Working in collaboration with CWG, Captivision and digiLED will design and create state-of-the-art LED and architectural media glass throughout the iconic campus, providing a vibrant platform for customer engagement and immersion across the spectrum of entertainment, information, and advertising. The initial Canary Wharf LED installation includes Adams Plaza and Thomson Reuters Plaza slated for completion in February, 2025.

07:36 EST Abeona Therapeutics expects cash to fund operations into 2026 - Cash, cash equivalents, short-term investments and restricted cash totaled $110.0 million as of September 30, 2024. As of June 30, 2024, cash, cash equivalents, short-term investments and restricted cash totaled $123.0 million. Abeona estimates that its current cash and cash equivalents, short-term investments and restricted cash, as well as its credit facility, are sufficient resources to fund operations into 2026, before accounting for any potential revenue from commercial sales of pz-cel, if approved, or proceeds from the sale of a Priority Review Voucher, if awarded by the FDA.

07:33 EST Singing Machine, Stingray announce karaoke partnership with BYD - Algorhythm Holdings (RIME) announces its subsidiary, The Singing Machine entered into a strategic partnership deal with BYD (BYDDF) and Stingray (STGYF). Singing Machine will be launching a globally available in-car karaoke microphone, designed to fully integrate with Stingray Karaoke app and BYD's infotainment system in its vehicles. The first-of-its-kind partnership will have enhanced karaoke features and proprietary technology that allows for unique vocal enhancements such as vocal effects and live pitch-detection for karaoke scoring.

07:30 EST Tilray Medical launches first commercial German grown medical cannabis products - Tilray Medical, a division of Tilray Brands, announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH facility. This launch marks the first medical cannabis products to be grown in Germany by Aphria RX under the newly issued medical cannabis cultivation license under MedCanG.

07:29 EST Aya Gold & Silver sees FY24 production 1.6M oz - 1.8M oz - On September 6, 2024, the Corporation announced a delay in commissioning due to an issue encountered by the EPC provider to correct the installation of the ball mill hydraulic unit. Along with this delay, the Corporation indicated it would revise 2024 production guidance. Production guidance is expected to be 1.6 - 1.8Moz for 2024. As a result of the delay in commissioning and its impact on the Corporation's prior production guidance, the Corporation is withdrawing all other guidance figures presented in the year-end 2023 MD&A and March 28, 2024 press release.

07:28 EST TransAlta to acquire Heartland Generation from Energy Capital for $542M - TransAlta announced that it has entered into an amending agreement to the share purchase agreement with an affiliate of Energy Capital Partners, ECP, the parent of Heartland Generation Ltd. and Alberta Power, relating to the previously announced acquisition of Heartland and its business operations by TransAlta. In order to meet the requirements of the federal Competition Bureau, TransAlta has also entered into a consent agreement with the Commissioner of Competition pursuant to which TransAlta has agreed to divest Heartland's Poplar Hill and Rainbow Lake assets following closing of the Transaction. Closing of the Transaction is expected to occur on or before December 4, 2024. In consideration of the Divestitures, TransAlta and ECP have agreed to a purchase price reduction of $80 million for the Transaction. ECP will be entitled to receive the proceeds from the sale of Poplar Hill and Rainbow Lake, net of certain adjustments following completion of the Divestitures. The net cash payment for the Transaction, before working capital adjustments, is estimated at $230 million, and will be funded through a combination of cash on hand and draws on its credit facilities.

07:25 EST Boralex to continue to work on various initiatives of Strategic Plan - Boralex's 2025 Strategic Plan is built around the same four strategic directions as the plan launched in 2019 - growth, diversification, customers and optimization - and six corporate targets. The details of the plan, which also sets out Boralex's corporate social responsibility strategy, are found in the Company's annual report. Highlights of the main achievements for the quarter ended September 30, 2024, in relation to the 2025 Strategic Plan can be found in the 2024 Interim Report 3, in the Investors section of the Boralex website. In the coming quarters, Boralex will continue to work on its various initiatives under the strategic plan, including project development, analysis of acquisition targets and optimization of power sales and operating costs. Finally, to fuel its organic growth, the Company has a pipeline of projects at various stages of development and construction defined on the basis of clearly identified criteria, totaling 7.2 GW of wind, solar and energy storage projects.

07:23 EST Appili Therapeutics shareholders vote in favor of Aditxt transaction - On November 6, 2024, shareholders of the Company overwhelmingly voted in favour of a special resolution approving a plan of arrangement pursuant to which Aditxt, through its wholly-owned subsidiary, Adivir, Inc. will acquire all of the issued and outstanding Class A common shares of the Company by way of a court-approved plan of arrangement under the Business Corporations Act. Approximately 29.50% of the outstanding Appili Shares were voted by shareholders and the Transaction was approved by 99.79% of the votes cast. Appili and Aditxt are in the process of satisfying the remaining closing conditions, which include: the Company obtaining final court approval for the Transaction, and Aditxt securing sufficient financing to complete the Transaction. Subject to satisfaction or waiver of the remaining closing conditions, Appili expects the Transaction to close in December 2024.

07:20 EST Bragg Gaming concludes review of strategic alternatives process - The Bragg board announced the strategic alternatives process in March with the formation of a special committee, comprised solely of independent members of the board. The committee, together with its advisors Oakvale Capital LLP and Blake, Cassels & Graydon LLP, evaluated a wide range of strategic alternatives for maximizing shareholder value including a potential sale or merger of the Company. Bragg solicited interest from a significant number of potential counterparties and received multiple non-binding proposals. After careful consideration, the board, on recommendation from the special committee, unanimously determined that none of the proposals received reflect the company's intrinsic value or current and projected financial performance, and therefore elected to conclude its review and disband the special committee.

07:13 EST Talen Energy sees FY24 adjusted EBITDA $750M-$780M - Sees FY24 adjusted free cash flow $265M-$285M

07:09 EST Iterum Therapeutics sees cash runway into 2025 - Cash, cash equivalents and short-term investments were $14.5 million at September 30, 2024. Based on Iterum's current operating plan, Iterum expects that its current cash, cash equivalents and short-term investments, including proceeds received from the exercise of certain warrants and amounts raised under an ATM offering subsequent to quarter-end through November 4, 2024, will be sufficient to fund its operations into 2025, including through the repayment date of the 6.500% Exchangeable Notes due January 31, 2025

07:07 EST Chemomab Therapeutics sees cash runway through beginning of 2026 - Cash and short-term bank deposits were $19.5 million as of September 30, 2024, as compared to $12.8 million as of June 30, 2024 and $19.9 million as of December 31, 2023. During the third quarter of 2024 Chemomab completed a private placement that resulted in gross proceeds to the company of approximately $10 million. Chemomab believes its existing liquidity resources as of September 30, 2024, will enable the company to fund its operations through the beginning of 2026.

06:57 EST Trimble receives expected delisting, deficiency notice from Nasdaq - Trimble received a staff delisting determination from Nasdaq, informing the company that Nasdaq has initiated a process which could result in the delisting of the company's common stock from Nasdaq as a result of the company not being in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the SEC. The company intends to appeal the staff determination before a Nasdaq Hearing Panel and seek a further stay of any suspension or delisting action pending the hearing process in accordance with the procedures set forth in the staff determination.

06:53 EST Merck enters exclusive global license for LM-299 - Merck and LaNova Medicines, a privately held clinical-stage biotechnology company, announced that Merck has entered into an exclusive global license to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova. Under the agreement, LaNova has granted Merck an exclusive global license to develop, manufacture and commercialize LM-299. LaNova will receive an upfront payment of $588M. LaNova is also eligible to receive up to $2.7B in milestone payments associated with the technology transfer, development, regulatory approval and commercialization of LM-299 across multiple indications. Closing of the proposed transaction is subject to approval under the Hart-Scott-Rodino Antitrust Improvements Act and other customary conditions. The transaction is expected to close in the fourth quarter of 2024. Merck expects to record a pre-tax charge relating to the $588M payment due upon closing to be included in GAAP and non-GAAP results in the quarter that the transaction closes, and the EPS impact of such charge will be disclosed at that time.

06:47 EST Capri Holdings announces termination of merger with Tapestry - Capri Holdings (CPRI) announced the mutual termination of its definitive merger agreement with Tapestry (TPR). Capri and Tapestry mutually agreed that terminating the merger agreement was in the best interests of both companies as the required closing condition of receiving necessary U.S. regulatory approvals was unlikely to be met by the merger agreement's outside date of February 10, 2025. The Company also announced its strategies to return to growth, which management will discuss on a call at 11:00 a.m. ET. The company will share more details of its strategies at an Investor Day in late February 2025. John Idol, the company's Chairman and Chief Executive Officer, said, "With the termination of the merger agreement, we are now focusing on the future of Capri and our three iconic luxury houses. Looking ahead, I remain confident in Capri's long-term growth potential for numerous reasons. First, we have an incredible portfolio of luxury houses, each with their own rich heritage, exclusive DNA and strong consumer loyalty. Second, we have a solid distribution network to build upon. With over 1,200 directly operated luxury retail locations globally combined with our robust digital platform we have a strong framework for the future. Additionally, our extensive wholesale network serves as an important channel to reach consumers in areas where we do not have our own stores. Third, we have the management team, design talent and a global workforce of 15,000 employees to successfully execute our initiatives. Fourth, we have the financial strength to implement our strategies." Idol concluded, "Given our company's performance over the past 18 months, we have recently started to implement a number of strategic initiatives to return our luxury houses to growth. Across Versace, Jimmy Choo and Michael Kors, we are focused on brand desirability through exciting communication, compelling product and omni-channel consumer experience. While our strategies are tailored uniquely for each brand, our overarching goals are similar."

06:45 EST Capri Holdings announces termination of merger with Tapestry

06:37 EST Advance Auto Parts announces asset optimization program - The company is executing a strategic plan to improve business performance with a focus on core retail improvements. The company has identified opportunities that it believes can improve adjusted operating income margin by more than 500-basis points through fiscal 2027. This strategic plan is anchored on three pillars outlined below to put the company on the path to deliver consistent profitable growth. Store operations: Reduction in U.S. asset footprint - closing 523 Advance corporate stores, exiting 204 independent locations, and closing four distribution centers. Standardization of store operating model and improving labor productivity. Acceleration in pace of new store openings. Merchandising excellence: Strategic sourcing to improve first costs and bring parts to market faster. Assortment management to enhance availability of parts. Pricing and promotions management to improve gross margin. Supply chain: Consolidation of distribution centers to operate 13 large facilities by 2026. Opening of 60 market hub locations by mid-2027. Optimization of transportation routes and freight to lower costs and improve productivity.

06:16 EST GSK announces Blenrep met key secondary endpoint in DREAMM-7 trial - GSK announced positive headline results from a planned interim analysis of the DREAMM-7 head-to-head phase III trial evaluating Blenrep in combination with bortezomib plus dexamethasone as a second-line or later treatment for relapsed or refractory multiple myeloma. The trial met the key secondary endpoint of overall survival, showing that belantamab mafodotin when combined with BorDex significantly reduced the risk of death versus standard of care daratumumab plus BorDex. Hesham Abdullah, Senior Vice President, Global Head Oncology, R&D, GSK, said: "The overall survival results from the DREAMM-7 trial underscore the potential for this Blenrep combination to extend the lives of patients with relapsed/refractory multiple myeloma. This is a statistically significant and clinically meaningful advancement for patients and potentially transformative for treatment. We look forward to sharing these data with health authorities and presenting the full results at next month's American Society of Hematology Annual Meeting."

06:12 EST Solidion to allocate portion of excess cash reserves to Bitcoin - Solidion announced a step forward in its corporate treasury strategy by allocating a significant portion of its excess cash reserves to Bitcoin. This move, alongside the broader pro-Bitcoin environment influenced by the recent election of a pro-crypto administration, solidifies the company's long-term belief in Bitcoin's role as a store of value and a strategic asset. Solidion will commit 60% of any excess cash from operations to Bitcoin purchases. Solidion will convert interest earnings on cash held in money market accounts to Bitcoin. Solidion will designate a percentage of funds to Bitcoin acquisitions to be held for the long-term.

06:06 EST BeiGene announces proposed name change to 'BeOne Medicines' - BeiGene announced its intent to change the company's name to "BeOne Medicines Ltd.," confirming its commitment to develop innovative medicines to eliminate cancer by partnering with the global community to serve as many patients as possible. The new name is part of a broader strategic growth plan that has enabled the company's global oncology leadership since its inception in 2010. The company recently reported $1B in quarterly total revenue driven by strong growth in product revenue in the U.S. and Europe. To support its expansive clinical portfolio and global growth, the company opened its $800M flagship clinical R&D and manufacturing facility at the Princeton West Innovation Campus in Hopewell, N.J. in July. Once the name is approved by shareholders, the company's stock ticker on Nasdaq will change to "ONC".

06:04 EST Enerflex lowers 2024 CapEx view to $80M-$90M from $90M-$110M

05:56 EST Jabil signs MoU with Gujarat state government - Jabil announced it has signed a memorandum of understanding, or MoU, with the Gujarat state government. The signing took place in Gandhinagar in the presence of Gujarat Chief Minister Bhupendra Patel. This agreement follows an MoU signing with the Tamil Nadu state in September. The two MoUs reflect Jabil's intentions to expand its footprint in India and will allow the company to explore long-term goals, opportunities and support with both states.

05:52 EST Accenture launches center for advanced AI in Kyoto - Accenture announced the opening of the Accenture Center for Advanced AI Kyoto, a facility dedicated to empowering clients with AI technologies, particularly generative AI, to drive the reinvention of their organizations. The center serves as a collaborative hub where clients can gain inspiration and forge new paths for their business transformations, which contribute to economic growth in Japan.

05:44 EST Zeekr announces strategic integration transactions with Geely - Zeekr announced its entry into strategic integration transactions with certain Geely entities, including Zhejiang Geely, a PRC limited liability company ultimately wholly-owned by Shufu Li and his associates, Volvo Cars Investment, a wholly-owned PRC subsidiary of Volvo Car AB, which itself is Geely Holding's indirect, non-wholly-owned subsidiary in Sweden, Ningbo Geely, a wholly-owned PRC subsidiary of Geely Automobile, Zeekr's controlling shareholder, and Lynk & Co Automotive Technology Co, a Chinese-foreign joint venture in China owned as to 50%, 20% and 30% respectively by Ningbo Geely, Geely Holding and VCI. Lynk & Co is principally engaged in the manufacture and sale of Lynk & Co brand vehicles and the after-sales parts. The strategic integration transactions are expected to close substantially concurrently, subject to the respective closing conditions set forth in the transaction documents. Upon completion, Lynk & Co will become Zeekr's indirect non-wholly-owned subsidiary, and the financial results of Lynk & Co will be consolidated into the financial statements of Zeekr. Zeekr's board of directors formed a committee of independent directors consisting of Miguel Lopez Ben, Stephen Brown Davis and Michael David Ricks, to consider and evaluate the strategic integration transactions. The committee was advised by its independent financial advisor, Houlihan Lokey, which delivered a fairness opinion stating that, as of the date of the opinion, the consideration to be paid by Zeekr in the equity transfer and the capital injection pursuant to the Lynk & Co equity transfer agreement and the Lynk & Co capital injection agreement is fair to the company from a financial point of view. Zeekr's board of directors, upon the unanimous recommendation of the committee, approved the strategic integration transactions. The company was notified that, also on November 14, a sale and purchase agreement was entered into between Geely International, a limited liability company incorporated in Hong Kong wholly owned by Geely Holding and Luckview Group, a limited liability company incorporated in the British Virgin Islands and a wholly-owned subsidiary of Geely Auto, pursuant to which GIHK will sell and Luckview will purchase approximately 11.3% of Zeekr's issued share capital for a consideration of $806.1M. Immediately after completion of this sale and purchase of Zeekr shares, Geely Auto's shareholding in Zeekr will increase to approximately 62.8%.

05:24 EST AirNet Technology regains compliance with Nasdaq - AirNet Technology announced that it received a written notice from the Listing Qualifications Staff of Nasdaq on November 12, notifying the company that it has regained compliance with the minimum market value of publicly held shares requirement under Nasdaq Listing Rule 5550(a)(5). The company was previously notified by the staff on September 18 that it was not in compliance with the MVPHS requirement due to its failure to maintain a minimum MVPHS of $1M for a period of 30 consecutive business days. Since then, the staff has determined that the company's MVPHS had been $1M or greater from October 28 through November 11. Therefore, the staff determined that the requirement was met on November 12.

05:08 EST Bilibili announces $200M share repurchase program - The company announced that its board of directors has authorized a share repurchase program under which the company may repurchase up to $200M of its publicly traded securities for the next 24 months. The company's shareholders have approved to grant an annual share repurchase mandate to its board of directors in accordance with the Hong Kong Listing Rules at the company's annual general meeting held on June 28, which shall be valid until the company's next annual general meeting unless revoked or varied. The company also plans to obtain its shareholders' approval for a share repurchase mandate at its next annual general meeting.